Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Engineering a Live Attenuated Porcine Epidemic Diarrhea Virus Vaccine Candidate via Inactivation of the Viral 2'-O-Methyltransferase and the Endocytosis Signal of the Spike Protein
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Engineering a Live Attenuated Porcine Epidemic Diarrhea Virus Vaccine Candidate via Inactivation of the Viral 2'-O-Methyltransferase and the Endocytosis Signal of the Spike Protein
Creator
Wang, Qiuhong
Hou, Yixuan
Yoo, Dongwan
Vlasova, Anastasia
Ke, Hanzhong
Su, Yunfang
Saif, Linda
Boley, Patricia
Chepngeno, Juliet
Kim, Jineui
An, Vlasova
Hou, Citation
Lj, Saif
Source
Medline; PMC
abstract
Porcine epidemic diarrhea virus (PEDV) causes high mortality in neonatal piglets; however, effective and safe vaccines are still not available. We hypothesized that inactivation of the 2′-O-methyltransferase (2′-O-MTase) activity of nsp16 and the endocytosis signal of the spike protein attenuates PEDV yet retains its immunogenicity in pigs. We generated a recombinant PEDV, KDKE(4A), with quadruple alanine substitutions in the catalytic tetrad of the 2′-O-MTase using a virulent infectious cDNA clone, icPC22A, as the backbone. Next, we constructed another mutant, KDKE(4A)-SYA, by abolishing the endocytosis signal of the spike protein of KDKE(4A). Compared with icPC22A, the KDKE(4A) and KDKE(4A)-SYA mutants replicated less efficiently in vitro but induced stronger type I and type III interferon responses. The pathogenesis and immunogenicities of the mutants were evaluated in gnotobiotic piglets. The virulence of KDKE(4A)-SYA and KDKE(4A) was significantly reduced compared with that of icPC22A. Mortality rates were 100%, 17%, and 0% in the icPC22A-, KDKE(4A)-, and KDKE(4A)-SYA-inoculated groups, respectively. At 21 days postinoculation (dpi), all surviving pigs were challenged orally with a high dose of icPC22A. The KDKE(4A)-SYA- and KDKE(4A)-inoculated pigs were protected from the challenge, because no KDKE(4A)-SYA- and one KDKE(4A)-inoculated pig developed diarrhea whereas all the pigs in the mock-inoculated group had severe diarrhea, and 33% of them died. Furthermore, we serially passaged the KDKE(4A)-SYA mutant in pigs three times and did not find any reversion of the introduced mutations. The data suggest that KDKE(4A)-SYA may be a PEDV vaccine candidate. IMPORTANCE PEDV is the most economically important porcine enteric viral pathogen and has caused immense economic losses in the pork industries in many countries. Effective and safe vaccines are desperately required but still not available. 2′-O-MTase (nsp16) is highly conserved among coronaviruses (CoVs), and the inactivation of nsp16 in live attenuated vaccines has been attempted for several betacoronaviruses. We show that inactivation of both 2′-O-MTase and the endocytosis signal of the spike protein is an approach to designing a promising live attenuated vaccine for PEDV. The in vivo passaging data also validated the stability of the KDKE(4A)-SYA mutant. KDKE(4A)-SYA warrants further evaluation in sows and their piglets and may be used as a platform for further optimization. Our findings further confirmed that nsp16 can be a universal target for CoV vaccine development and will aid in the development of vaccines against other emerging CoVs.
has issue date
2019-05-22
(
xsd:dateTime
)
bibo:doi
10.1128/jvi.00406-19
bibo:pmid
31118255
has license
bronze-oa
sha1sum (hex)
f9daabd834fda1a065a169d0da404604fd0a3544
schema:url
https://doi.org/10.1128/jvi.00406-19
resource representing a document's title
Engineering a Live Attenuated Porcine Epidemic Diarrhea Virus Vaccine Candidate via Inactivation of the Viral 2'-O-Methyltransferase and the Endocytosis Signal of the Spike Protein
has PubMed Central identifier
PMC6639265
has PubMed identifier
31118255
schema:publication
Journal of Virology
resource representing a document's body
covid:f9daabd834fda1a065a169d0da404604fd0a3544#body_text
is
schema:about
of
named entity 'SYA'
named entity 'development'
named entity 'group'
named entity 'SYA'
named entity 'SYA'
named entity 'KDKE'
named entity 'endocytosis'
named entity 'Endocytosis'
named entity 'Signal'
named entity 'Methyltransferase'
named entity 'DAYS'
named entity 'RESPONSES'
named entity 'OUR'
named entity 'IN VITRO'
named entity 'compared'
named entity 'pork'
named entity 'universal'
named entity 'piglets'
named entity 'hypothesized'
named entity 'virulence'
named entity 'pig'
named entity 'pigs'
named entity 'responses'
named entity 'piglets'
named entity 'protein'
named entity 'economic'
named entity 'KDKE'
named entity 'optimization'
named entity 'coronaviruses'
named entity 'endocytosis'
named entity 'Mortality rates'
named entity 'spike'
named entity 'caused'
named entity 'emerging'
named entity 'Next'
named entity 'SYA'
named entity 'porcine'
named entity 'SYA'
named entity 'development'
named entity 'inoculated'
named entity 'enteric'
named entity 'Viral'
named entity 'virulent'
named entity 'porcine'
named entity 'KDKE'
named entity 'severe diarrhea'
named entity 'KDKE'
named entity 'KDKE'
named entity 'diarrhea'
named entity 'highly conserved'
named entity 'PEDV'
named entity 'passaging'
named entity 'KDKE'
named entity 'KDKE'
named entity 'neonatal'
named entity 'KDKE'
named entity 'pig'
named entity 'spike protein'
named entity 'Endocytosis'
named entity 'Vaccine'
named entity 'mutants'
named entity 'mRNA'
named entity 'gene'
named entity 'wild-type'
named entity 'synonymous mutation'
named entity 'antibodies'
named entity 'subgenomic mRNA'
named entity 'vaccine'
named entity 'recombinant'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software